Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: September

Request Number: A-2023-001451

Request Summary: The Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate, which was accepted into review on or after March 1, 2022 but before December 1, 2022, received a notice/letter from Health Canada on November 2, 2022. If the sponsor submitted a Response to the notice: advise of the month and year that the Response was submitted; and provide a copy of the correspondence.

Disposition: Disclosed in part

Number of pages: 34

Date modified: